TNDM Q2 2025 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$241M+8.5% YoY

Gross Profit

$126M52.3% margin

Operating Income

-$52M-21.5% margin

Net Income

-$52M-21.8% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$16M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$876M

Total Liabilities

$742M

Stockholders' Equity

$133M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$241M	$222M	+8.5%
Gross Profit	$126M	$113M	+11.6%
Operating Income	-$52M	-$31M	-68.4%
Net Income	-$52M	-$31M	-70.1%

Revenue Segments

Supplies and Other

$129M54%

Pump

$112M46%

Geographic Segments

UNITED STATES

$170M71%

Non-US

$70M29%